A research team has developed an innovative nanomotor-based strategy to improve immunotherapy for bladder cancer. The study, ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

Avoiding surgery for rectal cancer, Sarah Rack of Memphis traveled to Houston for treatment every three weeks for 18 months.

Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows ...

Innovative urea-powered nanomotors show promise in bladder cancer treatment, improving immune activation and tumor growth ...

A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less ...

Optimizing treatment approaches in nested bladder tumors: A multicenter retrospective study.

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts. The study has significant relevance, ...

Genome-scale metabolic reconstruction of urinary microbiome: Pathway for personalized medicine. Frequency and impact of a genome-wide homologous recombination deficiency signature (HRDsig+) on the ...

While significant advances have been made in the treatment of bladder cancer over the last five years ... Understanding the roles, functions and responses of immune and non-immune cells in the bladder ...

Although the use of intravesical immunotherapy for reducing tumor progression or as ... surgical mainstay for the diagnosis and treatment of Ta and T1 bladder cancer. After this procedure, the ...